MIR LAB
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Welcome to the official website for the MIR Lab!
We are located at the University of Ottawa Heart Institute (UOHI) in Ottawa, Ontario, Canada. Directed by Dr. Hassan Mir, MD, FRCPC, MHI, MPH a cardiologist at UOHI. The Mir Lab comprises a dedicated team of researchers focused on advancing knowledge in cardiovascular prevention and rehabilitation.
The team is currently engaged in projects focused on hypertension, smoking and vaping cessation, and other areas of cardiovascular health.
For general comments, questions about our research, or information on getting involved with the Mir Lab as a volunteer, student, or collaborator, please contact Dr. Mir or Evyanne via our contact page.
Recent News!
We are proud to share that Dr. Hassan Mir, Principal Investigator of our lab, has been awarded the 2025 CCS-Novo Nordisk Cardiometabolic Research Award by the Canadian Cardiovascular Society.
This national award recognizes Dr. Mir’s impactful research in cardiometabolic health, with a particular focus on cardiovascular prevention, smoking and vaping cessation, hypertension, and patient-centred approaches to improving long-term health outcomes. His work bridges clinical care and research, advancing evidence-based strategies that support both individual patients and population-level prevention.
This recognition reflects Dr. Mir’s ongoing commitment to innovative, clinically relevant research and reinforces our lab’s mission to advance cardiovascular prevention through rigorous science and real-world impact.
We are excited to share that Dr. Hassan Mir, Principal Investigator of our lab, is a co-lead on a project selected for funding through the 2025 Translational Research Grant competition at the University of Ottawa Faculty of Medicine.
This initiative is part of a faculty-wide investment of over $100,000 aimed at accelerating research that bridges fundamental science and clinical application. Dr. Mir’s funded project, Uncovering the Hidden Effects of E-Cigarettes: Understanding the Biological Impact from Bench to Bedside, brings together preclinical and clinical expertise to examine the biological consequences of chronic e-cigarette exposure.
The project will investigate how vaping affects inflammation, oxidative stress, and tissue function, using animal models to identify key biomarkers that will then be evaluated in participants enrolled in ongoing vaping cessation trials. By integrating molecular findings with human data, this work aims to clarify the biological impact of vaping and inform future prevention, cessation, and public health strategies.
This funding highlights the strength of interdisciplinary collaboration and reflects our lab’s commitment to translational research that directly informs clinical care and population health.
Population Health/ Equity Training & Leadership Development
Get ready for the 18th Annual Ottawa Conference: State of the Art Clinical Approaches to Smoking Cessation, taking place January 23–24, 2026, at the Rogers Centre in Ottawa, Canada.
Email: her-crown@ottawaheart.ca
613-696-7000 ext. 15009
Quick Links